Link to this page
The Drug-Drug Interactions Ontology
| Preferred Name | zanamivir | |
| Synonyms |
(2R,3R,4S)-3-(acetylamino)-4-carbamimidamido-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid ZANAMIVIR 5-acetamido-2,6-anhydro-4-carbamimidamido-3,4,5-trideoxy-D-glycero-D-galacto-non-2-enonic acid Relenza C12H20N4O7 (2R,3R,4S)-4-[(diaminomethylidene)amino]-3-acetamido-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid 5-acetamido-2,6-anhydro-3,4,5-trideoxy-4-guanidino-D-glycero-D-galacto-non-2-enonic acid 5-(acetylamino)-2,6-anhydro-4-carbamimidamido-3,4,5-trideoxy-D-glycero-D-galacto-non-2-enonic acid GANA 4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid 4-guanidino-Neu5Ac2en zanamivir |
|
| ID |
http://purl.obolibrary.org/obo/CHEBI_50663 |
|
| AHFScode |
08:18.28
|
|
| altId |
CHEBI:46607 CHEBI:10104
|
|
| ATCCode |
J05AH01
|
|
| binds |
http://purl.obolibrary.org/obo/dinto_0989 |
|
| CASRN |
139110-80-8
|
|
| DBBrand |
relenza
|
|
| DBname |
zanamivir
|
|
| DBSynonym |
modified sialic acid gna gana zmr zanamavir
|
|
| Definition |
A guanidine that has formula C12H20N4O7.
|
|
| has effect |
http://purl.obolibrary.org/obo/OAE_0000388 http://purl.obolibrary.org/obo/OAE_0000567 http://purl.obolibrary.org/obo/OAE_0000660 http://purl.obolibrary.org/obo/OAE_0000310 http://purl.obolibrary.org/obo/OAE_0000400 |
|
| has pharmacological target | ||
| has role |
http://purl.obolibrary.org/obo/CHEBI_23924 |
|
| InChI |
InChI=1S/C12H20N4O7/c1-4(18)15-8-5(16-12(13)14)2-7(11(21)22)23-10(8)9(20)6(19)3-17/h2,5-6,8-10,17,19-20H,3H2,1H3,(H,15,18)(H,21,22)(H4,13,14,16)/t5-,6+,8+,9+,10+/m0/s1
|
|
| InChIKey |
InChIKey=ARAIBEBZBOPLMB-UFGQHTETSA-N
|
|
| inhibits |
http://purl.obolibrary.org/obo/dinto_0989 |
|
| label |
zanamivir
|
|
| prefixIRI |
obo2:CHEBI_50663
|
|
| prefLabel |
zanamivir
|
|
| SMILES |
[H][C@]1(OC(=C[C@H](NC(N)=N)[C@H]1NC(C)=O)C(O)=O)[C@H](O)[C@H](O)CO [H][C@]1(OC(=C[C@H](N=C(N)N)[C@H]1NC(C)=O)C(O)=O)[C@H](O)[C@H](O)CO
|
|
| Synonym |
(2R,3R,4S)-3-(acetylamino)-4-carbamimidamido-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid ZANAMIVIR 5-acetamido-2,6-anhydro-4-carbamimidamido-3,4,5-trideoxy-D-glycero-D-galacto-non-2-enonic acid Relenza C12H20N4O7 (2R,3R,4S)-4-[(diaminomethylidene)amino]-3-acetamido-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid 5-acetamido-2,6-anhydro-3,4,5-trideoxy-4-guanidino-D-glycero-D-galacto-non-2-enonic acid 5-(acetylamino)-2,6-anhydro-4-carbamimidamido-3,4,5-trideoxy-D-glycero-D-galacto-non-2-enonic acid GANA 4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid 4-guanidino-Neu5Ac2en zanamivir
|
|
| xref |
Wikipedia:Zanamivir PubChem Compound:60855 PharmGKB:PA164740891 DrugBank:DB00558 BindingDB:4934 PubChem Substance:46508581 PDB:ZMR RxList:http://www.rxlist.com/cgi/generic2/zanam.htm National Drug Code Directory:0173-0681-01 Drugs Product Database (DPD):2240863 ChEBI:50663 KEGG COMPOUND:C08095 Patent:US5360817 Beilstein:7083099 Drugs.com:http://www.drugs.com/cdi/zanamivir.html ChEMBL:473806 Wikipedia:http://en.wikipedia.org/wiki/Zanamivir PDBeChem:ZMR ChemSpider:54842 Patent:WO9116320 CASRN:139110-80-8 KEGG DRUG:D00902
|
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |